Today

Agents

Chat

Arena

Discover

More

App

Treace Medical Q2 EPS USD -0.24 - TMCI News | Rallies

Treace Medical Q2 EPS USD -0.24

TMCI•2026-08-07

Q2 results and outlook

Aug. 7 (Reuters) - Treace Medical Q2 revenue was USD 45.376 million versus the IBES estimate of USD 44 million.

Q2 gross profit was USD 35.607 million
Q2 gross margin was 78.5%
FY revenue outlook was USD 204-212 million versus the IBES estimate of USD 206.2 million

Related News

Instacart <CART.O>: Morgan Stanley Raises Target Price to $58.00 From $52.00

CART•2026-08-07

Soligenix Q2 net loss narrows as R&D expenses fall

SNGX•2026-08-07

Ardelyx, Inc. <ARDX.O>: Wedbush Cuts Target Price to $9 From $19

2026-08-07

Cloudflare <NET.N>: Truist Securities raises target price to $350 from $300

NET•2026-08-07

Unity Software Inc. <U.N>: Wedbush Raises Target Price to $50 From $36